Granules India Ltd
NSE:GRANULES

Watchlist Manager
Granules India Ltd Logo
Granules India Ltd
NSE:GRANULES
Watchlist
Price: 559.5 INR 2.69% Market Closed
Market Cap: 135.6B INR
Have any thoughts about
Granules India Ltd?
Write Note

Granules India Ltd
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Granules India Ltd
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Granules India Ltd
NSE:GRANULES
Common Shares Outstanding
â‚ą242.4m
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
2%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Common Shares Outstanding
â‚ą832.6m
CAGR 3-Years
71%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Common Shares Outstanding
â‚ą807.6m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Common Shares Outstanding
â‚ą2.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Common Shares Outstanding
â‚ą338.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
M
Mankind Pharma Ltd
NSE:MANKIND
Common Shares Outstanding
â‚ą400.6m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Granules India Ltd
Glance View

Market Cap
135.6B INR
Industry
Pharmaceuticals

Granules India Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 3,686 full-time employees. The firm operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The firm has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). The company has over seven manufacturing facilities, approximately six of which are located in India and one in the United States. The firm sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. Its wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.

GRANULES Intrinsic Value
517.35 INR
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Granules India Ltd's Common Shares Outstanding?
Common Shares Outstanding
242.4m INR

Based on the financial report for Jun 30, 2024, Granules India Ltd's Common Shares Outstanding amounts to 242.4m INR.

What is Granules India Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
2%

Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Granules India Ltd have been -1% over the past three years , -1% over the past five years , and 2% over the past ten years .

Back to Top